Beta-lactoglobulin peptides for treating cow's milk protein allergy

US9555103B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9555103-B2
Application numberUS-201214362545-A
CountryUS
Kind codeB2
Filing dateDec 6, 2012
Priority dateDec 7, 2011
Publication dateJan 31, 2017
Grant dateJan 31, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a nutritional, preferably enteral, composition for use in the treatment of cow's milk allergy in infants allergic to cow's milk containing specific beta-lactoglobulin peptides, which are able to reduce, in particular abolish the acute symptoms of cow's milk protein allergy.

First claim

Opening claim text (preview).

The invention claimed is: 1. A nutritional composition for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants, the nutritional composition comprising at least one beta-lactoglobulin peptide comprising an amino acid sequence consisting of 18 to 30 amino acids and having an amino acid sequence selected from the group consisting of SEQ ID NO 1, SEQ ID NO 2, and SEQ ID NO 3, wherein the composition comprises 10 to 5000 μg of the at least one beta-lactoglobin peptide per g of total protein in the composition. 2. The nutritional composition for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants according to claim 1 , comprising as a further protein component free amino acids and/or extensively hydrolyzed proteins. 3. The nutritional composition for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants according to claim 1 , comprising at least one non-digestible oligosaccharide selected form the group consisting of fructo-oligosaccharide, non-digestible dextrin, galacto-oligosaccharide, xylo-oligosaccharide, arabino-oligosaccharide, arabinogalacto-oligosaccharide, gluco-oligosaccharide, glucomanno-oligosaccharide, galactomanno-oligosaccharide, mannan-oligosaccharide, chito-oligosaccharide, uronic acid oligosaccharide, sialyl-oligosaccharide and fuco-oligosaccharide. 4. The nutritional composition for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants according to claim 3 , wherein the non-digestible oligosaccharide is a short-chain or long-chain fructo-oligosaccharide. 5. The nutritional composition for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants according to claim 1 , comprising a lipid component and at least one digestible carbohydrate. 6. The nutritional composition for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants according to claim 1 , wherein the composition comprises a total amount of protein of 5 to 25° A) based on dry weight of the composition. 7. The nutritional composition for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants according to claim 3 , wherein the composition comprises 0.05 to 20 wt. % of the at least one non-digestible oligosaccharide based on dry weight of the composition. 8. The nutritional composition for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants according to claim 5 , wherein the composition comprises 15 to 40% of the lipid component based on dry weight of the composition. 9. The nutritional composition for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants according to claim 1 , which is an infant formula or a follow-on-formula. 10. The nutritional composition for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants according to claim 1 , which is in the form of a dry powder or a ready to feed liquid. 11. A nutritional composition comprising at least one beta-lactoglobulin peptide comprising an amino acid sequence consisting of 18 to 30 amino acids and having an amino acid sequence selected from the group consisting of SEQ ID NO 1, SEQ ID NO 2, and SEQ ID NO 3, wherein the composition comprises 10 to 5000 μg of the at least one beta-lactoglobin peptide per g of total protein in the composition, and wherein the at least one beta-lactoglobulin peptide is for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants. 12. A nutritional composition comprising a protein component, a lipid component and digestible carbohydrates, wherein the protein component consists of i) the at least one beta-lactoglobulin peptide according to claim 1 , and ii) at least one further protein component selected from the group consisting of extensively hydrolysed protein and free amino acids, wherein in sum of i) and ii) accounts for at least 95 wt. % of the protein component, and wherein the lipid component comprises at least 0.1 wt. % DHA based on total fatty acids. 13. The nutritional composition according to claim 12 , comprising at least one non-digestible oligosaccharide, wherein the non-digestible oligosaccharide is a short-chain or long-chain fructo-oligosaccharide. 14. The nutritional composition according to claim 12 , wherein the composition comprises a total amount of protein of 5 to 25° A) based on dry weight of the composition. 15. The nutritional composition according to claim 12 , which is an infant formula or a follow-on-formula. 16. The nutritional composition according to claim 12 , which is an infant formula or a follow-on-formula for use in feeding cow's milk protein allergic infants. 17. The nutritional composition for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants according to claim 1 , wherein the at least one beta-lactoglobulin peptide is SEQ DI NO 3. 18. A nutritional composition comprising at least one beta-lactoglobulin peptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NO 1, SEQ ID NO 2, and SEQ ID NO 3. 19. The nutritional composition according to claim 18 , further comprising a protein component selected from the group consisting of hydrolysed whey protein, free amino acids, soy proteins, hydrolysed soy proteins, pea proteins, hydrolysed pea proteins, rice proteins, hydrolysed rice proteins, collagen, hydrolysed collagen, and mixtures thereof. 20. The nutritional composition according to claim 18 , further comprising a lipid component and a carbohydrate component.

Assignees

Inventors

Classifications

  • Peptides; Protein hydrolysates · CPC title

  • Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title

  • Dairy proteins · CPC title

  • A61K39/35Primary

    Allergens · CPC title

  • A23L33/40Primary

    Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9555103B2 cover?
The present invention relates to a nutritional, preferably enteral, composition for use in the treatment of cow's milk allergy in infants allergic to cow's milk containing specific beta-lactoglobulin peptides, which are able to reduce, in particular abolish the acute symptoms of cow's milk protein allergy.
Who is the assignee on this patent?
Nutricia Nv
What technology area does this patent fall under?
Primary CPC classification A61K39/35. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).